Potentiation of arsenic neurotoxicity by folate deprivation: Protective role of S-adenosyl methionine

Nutritional Neuroscience

Volumn 10, Issue 5-6, 2007, Pages 199-204

  Dubey, Maya ^a   Shea, Thomas B ^a  

^a UNIVERSITY OF MASSACHUSETTS LOWELL   (United States)

Author keywords

Amyotropic lateral sclerosis; Arsenic; Folate; Neurofilament; S adenosyl methionine

Indexed keywords

ARSENIC; FOLIC ACID; NEUROTOXIN; S ADENOSYLMETHIONINE;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; FOLIC ACID DEFICIENCY; GENETIC TRANSFECTION; METHYLATION; MOUSE; NERVE CELL CULTURE; NERVE FIBER; NEURITE; NEUROFILAMENT; NEUROTOXICITY; NONHUMAN; PERIKARYON; PRIORITY JOURNAL;

AMYOTROPHIC LATERAL SCLEROSIS; ARSENIC; AXONS; BUCLADESINE; CELL LINE; CYTOSKELETON; FOLIC ACID; GREEN FLUORESCENT PROTEINS; METHYLATION; NERVOUS SYSTEM DISEASES; NEURITES; NEUROFILAMENT PROTEINS; PHOSPHORYLATION; RECOMBINANT FUSION PROTEINS; S-ADENOSYLMETHIONINE; TRANSFECTION;

EID: 37849031045     PISSN: 1028415X     EISSN: 14768305     Source Type: Journal    
DOI: 10.1080/10284150701562703     Document Type: Article

References (62)

1. Anderton, BH, Breinburg, D., Downes, MJ, Green, PJ, Tomlinson, BE, Ulrich, J., Wood, JN and Kahn, J. (1982) Monoclonal antibodies show that neurofibrillary tangles and neurofilaments share antigenic determinants. Nature, 298, pp. 84-86.
2. Aposhian, HV (1997) Enzymatic methylation of arsenic species and other new approaches to arsenic toxicity. Annu Rev Pharmacol Toxicol, 37, pp. 397-419.
3. Aposhian, HV, Zakharyan, RA, Avram, MD, Kopplin, MJ and Wollenberg, ML (2003) Oxidation and detoxification of trivalent arsenic species. Toxicol Appl Pharmacol, 193, pp. 1-8.
4. Black, MM and Lee, VM-Y (1988) Phosphorylation of neurofilament proteins in intact neurons: Demonstration of phosphorylation in cell bodies and axons. J Neurosci, 8, pp. 3296-3305.
5. Chan, WK-C, Dickerson, A., Otriz, D., Pimenta, A., Moran, C., Malik, K., Motil, J., Snyder, S., Pant, HC and Shea, TB (2004) Mitogen activated protein kinase regulates neurofilament axonal transport. J Cell Sci, 117, pp. 4629-4642.
6. Chattopadhyay, S., Bhaumik, S. and Chaudhury, A S Nag (2002) Arsenic induced changes in growth development and apoptosis in neonatal and adult brain cells in vivo and in tissue culture. Toxicol Lett, 128, pp. 73-84.
7. Chattopadhyay, S., Bhaumik, S., Purkayastha, M., Basu, S., Chaudhuri, AN and Gupta, SD (2002) Apoptosis and necrosis in developing brain cells due to arsenic toxicity and protection with antioxidants. Toxicol Lett, 136, pp. 65-76.
8. Chen, J., Zhou, J., Feng, Y. and Wang, J. (2005) Effect of GSK-3 overactivation on neurofilament phosphorylation. J Huazhong Univ Sci Technolog Med Sci, 25, pp. 375-377.
9. Cooper, KL, Liu, KJ and Hudson, LG (2006) Contributions of reactive oxygen species and mitogen-activated protein kinase signaling in arsenite-stimulated hemeoxygenase-1 production. Toxicol Appl Pharmacol, 2006
10. Crandall, LZ and Vorce, RL (2002) Differential effects of arsenic on folate binding protein 2 (Folbp2) null and wild type fibroblasts. Toxicol Lett, 136:1, pp. 43-54.
11. DeFuria, J., Chen, P. and Shea, TB (2006) Divergent effects of the MEKK-1/JNK pathway on NB2a/d1 differentiation: Some activity is required for outgrowth and stabilization of neurites but overactivation inhibits both phenomena. Brain Res, 1123, pp. 20-26.
12. Eizirik, DL, Spencer, P. and Kisby, GE (1996) Potential role of environmental genotoxic agents in diabetes mellitus and neurodegenerative diseases. Biochem Pharmacol, 51, pp. 1585-1591.
13. Ferm, VH and Hanlon, DP (1986) Arsenate-induced neural tube defects not influenced by constant rate administration of folic acid. Pediatr Res, 20, pp. 761-762.
14. Gabbianelli, R., Ferri, A., Rotilio, G. and Carri, MT (1999) Aberrant copper chemistry as a major mediator of oxidative stress in a human cellular model of amyoptropic lateral sclerosis. J Neurochem, 73, pp. 1175-1180.
15. Gamble, MV, Liu, X., Ahsan, H., Pilsner, R., Ilievski, V., Slavkovich, V., Parvez, F., Levy, D., Factor-Litvak, P. and Graziano, JH (2005) Folate, homocysteine, and arsenic metabolism in arsenic-exposed individuals in Bangladesh. Environ Health Perspect, 113, pp. 1683-1688.
16. Gamble, MV, Liu, X., Ahsan, H., Pilsner, JR, Ilievski, V., Slavkovich, V., Parvez, F., Chen, Y., Levy, D., Factor-Litvak, P. and Graziano, JH (2006) Folate and arsenic metabolism: A double-blind, placebo-controlled folic acid-supplementation trial in Bangladesh. Am J Clin Nutr, 84, pp. 1093-1101.
17. Gefrides, LA, Bennett, GD and Finnell, RH (2002) Effects of folate supplementation on the risk of spontaneous and induced neural tube defects in splotch mice. Teratology, 65, pp. 63-69.
18. Giafis, N., Katsoulidis, E., Sassano, A., Tallman, MS, Higgins, LS, Nebreda, AR, Davis, RJ and Platanias, LC (2006) Role of the p38 mitogen-activated protein kinase pathway in the generation of arsenic trioxide-dependent cellular responses. Cancer Res, 66, pp. 6763-6771.
19. Ho, PI, Ortiz, D., Rogers, E. and Shea, TB (2002) Multiple aspects of homocysteine neurotoxicity: Glutamate excitotoxicity, kinase hyperactivation and DNA damage. J Neurosci Res, 70, pp. 694-702.
20. Ho, P., Ashline, D., Dhitavat, S., Ortiz, D., Collins, SC, Rogers, E. and Shea, TB (2003) Folate deprivation induces neurodegeneration: Roles of oxidative stress and increased homocysteine. Neurobiol Dis, 14, pp. 32-42.
21. Julien, J-P and Mushynski, WE (1998) Neurofilaments in health and disease. Prog Nucleic Acid Res Mol Biol, 61, pp. 1-20.
22. Jung, C., Yabe, J., Wang, F-S and Shea, TB (1998) Neurofilaments are present within axonal neurites before incorporation into triton-insoluble structures. Cell Motil Cytoskel, 40, pp. 44-58.
23. Kajiguchi, T., Yamamoto, K., Iida, S., Ueda, R., Emi, N. and Naoe, T. (2006) Sustained activation of c-jun-N-terminal kinase plays a critical role in arsenic trioxide-induced cell apoptosis in multiple myeloma cell lines. Cancer Sci, 97, pp. 540-545.
24. Kannan, GM and Flora, SJ (2006) Combined administration of N-acetylcysteine and monoisoamyl DMSA on tissue oxidative stress during arsenic chelation therapy. Biol Trace Elem Res, 110:1, pp. 43-59.
25. Kannan-Thulasiraman, P., Katsoulidis, E., Tallman, MS, Arthur, JS and Platanias, LC (2006) Activation of the mitogen- and stress-activated kinase 1 by arsenic trioxide. J Biol Chem, 281, pp. 22446-22452.
26. Kim, HJ, Kim, M., Kim, SH, Sung, JJ and Lee, KW (2002) Alteration in intracellular calcium homeostasis reduces motor neuronal viability expressing mutated Cu/Zn superoxide dismutase through a nitric oxide/ guanylyl cyclase cGMP cascade. Neuron, 13, pp. 1131-1135.
27. Kruman, II, Culmsee, C., Chan, SL, Kruman, Y., Guo, Z., Penix, L. and Mattson, MP (2000) Homocysteine elicits a DNA damage response in neurons that promotes apoptosis and hypersensitivity to excitotoxicity. J Neurosci, 20, pp. 6920-6926.
28. Kruman, II, Kumaravel, TS, Lohani, A., Pedersen, WA, Roy, G., Cutler, RG, Kruman, Y., Haughey, N Norman, Lee, J., Evans, M Michele and Mattson, MP (2002) Folic acid deficiency and homocysteine impair DNA repair in hippocampal neurons and sensitize them to amyloid toxicity in experimental models of Alzheimer's disease. J Neurosci, 22, pp. 1752-1762.
29. Li, W. and Chou, IN (1992) Effects of sodium arsenite on the cytoskeleton and cellular glutathione levels in cultured cells. Toxicol Appl Pharmacol, 114, pp. 132-139.
30. Lin, S., Shi, Q., Nix, FB, Styblo, M., Beck, MA, Herbin-Davis, KM, Hall, LL, Simeonsson, JB and Thomas, DJ (2002) A novel S-adenosyl--methionine: Arsenic(III) methyltransferase from rat liver cytosol. J Biol Chem, 277, pp. 10795-10803.
31. Liu, J., Xie, Y., Ward, JM, Diwan, BA and Waalkes, MP (2004) Toxicogenomic analysis of aberrant gene expression in liver tumors and nontumorous livers of adult mice exposed in utero to inorganic arsenic. Toxicol Sci, 77, pp. 249-257.
32. Loenen, WA (2006) S-adenosylmethionine: Jack of all trades and master of everything?. Biochem Soc Trans, 34, pp. 330-333.
33. Mattson, MM and Shea, TB (2002) Folate and homocysteine in neural plasticity and neurodegenerative disorders. Trends Neurosci, 26, pp. 137-146.
34. Mizrahi, EH, Jacobsen, DW, Debanne, SM, Traore, F., Lerner, AJ, Friedland, RP and Petot, GJ (2003) Plasma total homocysteine levels, dietary vitamin B6 and folate intake in ad and healthy aging. J Nutr Health Aging, 7:3, pp. 160-165.
35. Modi, M., Kaul, RK, Kannan, GM and Flora, SJ (2006) Co-administration of zinc and N-acetylcysteine prevents arsenic-induced tissue oxidative stress in male rats. J Trace Elem Med Biol, 20:3, pp. 197-204.
36. Nagaraja, TN and Desiraju, T. (1993) Regional alterations in the levels of brain biogenic amines, glutamate, GABA, and GAD activity due to chronic consumption of inorganic arsenic in developing and adult rats. Bull Environ Contam Toxicol, 50, pp. 100-107.
37. Namgugn, U. and Xia, Z. (2001) Arsenic induces apoptosis in rat cerebellar neurons via activation of JNK3 and p38 MAP kinases. Toxicol Appl Pharmacol, 174, pp. 130-138.
38. Pant, HC and Veeranna (1995) Neurofilament phosphorylation. Biochem Cell Biol, 73, pp. 575-592.
39. Piga, R., Saito, Y., Yoshida, Y. and Niki, E. (2006) Cytotoxic effects of various stressors on PC12 cells: Involvement of oxidative stress and effect of antioxidants. Neurotoxicology
40. Potin, S., Bertoglio, J. and Breard, J. (2007) Involvement of a Rho-ROCK-JNK pathway in arsenic trioxide-induced apoptosis in chronic myelogenous leukemia cells. FEBS Lett, 581, pp. 118-124.
41. Ramirez, T., Garcia-Montalvo, V., Wise, C., Cea-Olivares, R., Poirier, LA and Herrera, LA (2003) S-adenosy-l-methionine is able to reverse micronucleus formation induced by sodium arsenite and other cytoskeleton disrupting agents in cultured human cells. Mutat Res, 528, pp. 61-74.
42. Rao, M. and Nixon, RA (2003) Defective neurofilament transport in mouse models of amyotrophic lateral sclerosis: A review. Neurochem Res, 28:7, pp. 1041-1047.
43. Schuliga, M., Chouchane, S. and Snow, ET (2002) Upregulation of glutathione-related genes and enzyme activities in cultured human cells by sublethal concentrations of inorganic arsenic. Toxicol Sci, 70, pp. 183-192.
44. Shalat, SL, Walker, DB and Finnell, RH (1996) Role of arsenic as a reproductive toxin with particular attention to neural tube defects. J Toxicol Environ Health, 48:3, pp. 253-272.
45. Shea, TB and Rogers, E. (2002) Homocysteine as a risk factor for Alzheimer's disease. N Engl J Med, p. 346.
46. Shea, TB and Rogers, E. (2002) Folate quenches oxidative damage in brains of apolipoprotein E-deficient mice: Augmentation by vitamin E. Mol Brain Res, 108, pp. 1-6.
47. Shea, TB, Rogers, E., Ortiz, D. and Sheu, M-S (2002) Apolipoprotein-E deficiency promotes increased oxidative stress and compensatory increases in antioxidants in brain tissue. J Free Radic Biol Med, 33, pp. 1115-1120.
48. Shibata, N. (2001) Transgenic mouse model for familial amyotrophic lateral sclerosis with superoxide dismutase-1 mutation. Neuropathology, 21, pp. 82-92.
49. Strong, M. (2003) The basics of therapeutics in amyotrophic lateral sclerosis. Pharmacol Ther, 5542, pp. 1-36.
50. Sung, JJ, Kim, HJ, Choi-Kwon, S., Lee, J., Kim, M. and Lee, KW (2002) Homocysteine induces oxidative cytotoxicity in Cu,Zn-superoxide dismutase mutant motor neuronal cell. Neuroreport, 13, pp. 377-381.
51. Tchantchou, F., Graves, M., Ortiz, D. and Shea, TB (2006) S-adenosyl methionine: A link between nutritional and genetic risk factors in Alzheimer's disease. J Nutr Health Aging, 10, pp. 541-544.
52. Tjiattas, L., Ortiz, D., Dhivant, S Sirikarnt, Mitton, K., Rogers, E. and Shea, TB (2004) Folate deficiency and homocysteine induce toxicity in cultured dorsal root ganglion neurons via cytosolic calcium accumulation. Aging Cell, 3, pp. 71-76.
53. Vahidnia, A., Romijn, F., Tiller, M., van der Voet, GB and de Wolff, FA (2006) Arsenic-induced toxicity: Effect on protein composition in sciatic nerve. Hum Exp Toxicol, 25:11, pp. 667-674.
54. Henegouwen, PM van Bergen en and Linnemans, AM (1987) Heat shock gene expression and cytoskeletal alterations in mouse neuroblastoma cells. Exp Cell Res, 171, pp. 367-375.
55. Bosch, L Van Den, Vandenberghe, W., Klaassen, H., Van Houtte, E. and Robberecht, W. (2000) Ca(2+)-permeable AMPA receptors and selective vulnerability of motor neurons. J Neurol Sci, 180:1, pp. 29-34.
56. White, F., Nicoll, JA, Roses, AD and Horsburgh, K. (2001) Impaired neuronal plasticity in transgenic mice expressing human apolipoprotein E4 compared to E3 in a model of entorhinal cortex lesion. Neurobiol Dis, 8, pp. 611-625.
57. Wlodarczyk, B., Spiegelstein, O., Waes, J Gelineau-van, Vorce, RL, Lu, X., Le, CX and Finnell, RH (2001) Arsenic-induced congenital malformations in genetically susceptible folate binding protein-2 knockout mice. Toxicol Appl Pharmacol, 177, pp. 238-246.
58. Wlodarczyk, BJ, Cabrera, RM, Hill, DS, Bozinov, D., Zhu, H. and Finnell, RH (2006) Arsenic-induced gene expression changes in the neural tube of folate transport defective mouse embryos. Neurotoxicology, 27, pp. 547-557.
59. Yabe, JT, Chylinski, TM, Wang, F-S, Pimenta, AF, Kattar, SD, Linsley, M-D, Chan, WK-H and Shea, TB (2001) Neurofilaments consist of distinct populations that can be distinguished by C-terminal phosphorylation, bundling and axonal transport rate in growing axonal neurites. J Neurosci, 21, pp. 2195-2205.
60. Yoshida, T., Yamauchi, H. and Sun, G Fan (2004) Chronic health effects in people exposed to arsenic via the drinking water: Dose-response relationships in review. Toxicol Appl Pharmacol, 198, pp. 243-252.
61. Yoshino, Y. (1984) Possible involvement of folate cycle in the pathogenesis of amyotrophic lateral sclerosis. Neurochem Res, 9, pp. 387-391.
62. Zakharyan, RA, Ayala-Fierro, F., Cullen, WR, Carter, DM and Aposhian, HV (1999) Enzymatic methylation of arsenic compounds VII. monomethylarsonous acid (MMAIII) is the substrate for MMA methyltransferase of rabbit liver and human hepatocytes. Toxicol Appl Pharmacol, 158, pp. 9-15.